Disease/Infection News

RSS

New profiling procedure reveals role of immunoresolvents in blood coagulation

Stopping a wound from bleeding is essential for human health. Blood coagulation - in which blood goes from liquid to gel and forms a clot - can prevent excessive bleeding and infection. But exactly what molecular events transpire when blood coagulates has remained somewhat mysterious.

4 Aug 2017

Molecular tests that detect drug-resistant TB may become faster alternative to traditional testing

Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death has remained unclear.

4 Aug 2017

Robot emits UV light to destroy infection-causing bugs in hard-to-clean places

Hospitals around the world are looking for new and innovative ways to battle deadly pathogens and kill multidrug resistant organisms that can cause hospital-acquired infections, or HAI.

4 Aug 2017

Prior flavivirus disease does not worsen Zika infection in rhesus macaques

Rhesus macaques previously infected with dengue or yellow fever viruses appear to be neither more nor less susceptible to severe infection with Zika virus, according to new research published in PLOS Pathogens.

4 Aug 2017

Mouse model developed to allow study of Zika virus transmission

Scientists at the National Institutes of Health have developed a mouse model to study the sexual and fetal transmission of Zika virus. This will enable studies to further understanding of how the Zika virus spreads, thereby allowing treatments to be developed.

4 Aug 2017

New study shows how gut microbes can prevent severe flu infections in mice

Microbes that live in the gut don't just digest food. They also have far-reaching effects on the immune system.

3 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

HIV prevention drug to be trialed by Britain's NHS

After a High Court case, an HIV prevention drug is soon to be available on the NHS. NHS England has issued a statement saying that pre-exposure prophylaxis (PrEP) treatment for HIV shall be available to an initial 10,000 people for a trial period of three years.

3 Aug 2017

UM SOM awarded $2.47 million grant to develop vaccine against Shigella, ETEC infections

The University of Maryland School of Medicine has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal diseases in young children in developing countries and a common cause of "traveler's diarrhea" among travelers to these countries.

3 Aug 2017

Study finds high rates of drug resistance to urinary tract infections in Bangladesh

Organisms causing urinary tract infections (UTI) are increasingly proving to be ineffective or showing resistance to drugs that are used to kill the germs. This phenomenon has been increasing worldwide, especially to commonly used antimicrobials (drugs) in children.

3 Aug 2017

Injectable ART may have same effectiveness as standard oral treatments

Antiretroviral therapy (ART) intramuscularly administered may have the same effectiveness as current oral treatments.

3 Aug 2017

Tiny molecule in the immune system could help develop cure for common cold

A tiny molecule found in the immune systems of humans and animals could be used to develop a cure for the common cold, new research suggests.

3 Aug 2017

AbbVie hosts roundtable meeting to agree priority actions needed to eliminate hepatitis C in London

Representatives from the London Assembly and local authorities in the Capital are set to meet with third sector and public health representatives in a roundtable meeting hosted by biopharmaceutical company, AbbVie, on World Hepatitis Day.

3 Aug 2017

UNM professor receives $1.9-million NIH grant to battle against pervasive African parasite

UNM Distinguished Professor of Biology Eric S. Loker began studying the parasite that causes this disease more than three decades ago and is widely considered one of the world's foremost experts in this field. Loker was recently awarded a five-year, $1.9-million grant from the National Institutes of Health to continue his work in Africa.

2 Aug 2017

Sexual transmission of Zika virus reported in Florida

Yesterday, Florida Department of Health reported the first case of sexually transmitted Zika virus this year.

2 Aug 2017

InDevR gets NIAID support for verification, validation studies on new potency test for influenza viruses

InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced support from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for verification and validation studies on a new potency test for influenza viruses with pandemic potential.

2 Aug 2017

Study shows how climate change affects Europe's most dangerous pathogens

The impact of climate change on the emergence and spread of infectious diseases could be greater than previously thought, according to new research by the University of Liverpool.

2 Aug 2017

Researchers identify new methods that could improve treatment for infectious diseases

Researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage. The findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.

2 Aug 2017

Cardiovascular disease risk increases after hospital admission for sepsis or pneumonia

Pneumonia or sepsis in adults that results in hospital admission is associated with a six-fold increased risk of cardiovascular disease in the first year, according to research published today in the European Journal of Preventive Cardiology.

2 Aug 2017

Latency reversing agent makes dormant HIV-infected cells vulnerable to clearance

The ability for HIV to hide in the body in a dormant state makes curing the 40 million people living with the virus a challenge. Researchers at the University of North Carolina at Chapel Hill have shown the drug Vorinostat reverses this latency, causing resting CD4 T-cells to express HIV.

1 Aug 2017

Disease/Infection News

New profiling procedure reveals role of immunoresolvents in blood coagulation

Molecular tests that detect drug-resistant TB may become faster alternative to traditional testing

Robot emits UV light to destroy infection-causing bugs in hard-to-clean places

Prior flavivirus disease does not worsen Zika infection in rhesus macaques

Mouse model developed to allow study of Zika virus transmission

New study shows how gut microbes can prevent severe flu infections in mice

FDA approves new treatment for all HCV genotypes 1-6

HIV prevention drug to be trialed by Britain's NHS

UM SOM awarded $2.47 million grant to develop vaccine against Shigella, ETEC infections

Study finds high rates of drug resistance to urinary tract infections in Bangladesh

Injectable ART may have same effectiveness as standard oral treatments

Tiny molecule in the immune system could help develop cure for common cold

AbbVie hosts roundtable meeting to agree priority actions needed to eliminate hepatitis C in London

UNM professor receives $1.9-million NIH grant to battle against pervasive African parasite

Sexual transmission of Zika virus reported in Florida

InDevR gets NIAID support for verification, validation studies on new potency test for influenza viruses

Study shows how climate change affects Europe's most dangerous pathogens

Researchers identify new methods that could improve treatment for infectious diseases

Cardiovascular disease risk increases after hospital admission for sepsis or pneumonia

Latency reversing agent makes dormant HIV-infected cells vulnerable to clearance

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News